Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting primary and secondary mediation analyses of randomised trials and observational studies.
|Full bibliographic reference
|Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, MacKinnon DP, Mansell G, Collins GS, Golub RM, McAuley JH; AGReMA group, Localio AR, van Amelsvoort L, Guallar E, Rijnhart J, Goldsmith K, Fairchild AJ, Lewis CC, Kamper SJ, Williams CM, Henschke N. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement. JAMA. 2021;326(11):1045-1056.
(full-text if available)
|Access the AGReMA checklist for reporting mediation analyses of randomised controlled trials and observational studies as a primary objective.
Access the AGReMA-SF checklist for reporting secondary mediation analyses within primary reports of randomised controlled trials and observational studies.
|Reporting guideline website URL
|Reporting guideline acronym
|Clinical trials, Experimental studies, Observational studies
|Applies to the whole report or to individual sections of the report?
|Statistical methods and analyses
|Read about the development of the AGReMA reporting guideline.
|Record last updated on
|September 23, 2021
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.